quadraScope Ventures

quadraScope Ventures is a venture capital firm specializing in the rejuvenation medicine sector, investing in early-stage healthcare companies developing pharmaceuticals, diagnostics, software, equipment, and devices aimed at biological age reversal, disease treatment, prevention, and longevity. The firm focuses on addressing the biological mechanisms of aging to extend human healthspan.

The firm's investment strategy targets companies at various stages, including Pre-Seed, Seed, Series A, Series B, and Series C, with a minimum investment size of $250,000 and a maximum of $3 million. Their portfolio encompasses sectors such as biotechnology and life sciences, reflecting a commitment to advancing healthspan-enhancing innovations.

With a presence in Boston, Massachusetts, quadraScope Ventures leverages its strategic location in a leading biotech hub to identify and support emerging companies in the longevity space. The firm's team comprises professionals with a strong track record in private equity and a deep understanding of the rejuvenation industry, enabling them to effectively select and vet investment opportunities in this rapidly evolving field.